On the public citation graph

Insight into the Structural Requirements of Urokinase-Type Plasminogen Activator Inhibitors Based on 3D QSAR CoMFA/CoMSIA Models

0 signed · 55 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cem.1180070407openalex-snapshot
A test of significance for partial least squares regression
inferredcites →https://doi.org/10.1002/qsar.19930120205openalex-snapshot
The Probability of Chance Correlation Using Partial Least Squares (PLS)
inferredcites →https://doi.org/10.1006/jmbi.2000.3966openalex-snapshot
Crystals of the urokinase type plasminogen activator variant βc-uPA in complex with small molecule inhibitors open the way towards structure-based drug design 1 1Edited by A. Fersht
inferredcites →https://doi.org/10.1007/978-94-017-1026-8_2openalex-snapshot
Multivariate Data Analysis in Chemistry
inferredcites →https://doi.org/10.1007/bf00049524openalex-snapshot
The role of urokinase-type plasminogen activator in aggressive tumor cell behavior
inferredcites →https://doi.org/10.1007/bf00128336openalex-snapshot
MOPAC: A semiempirical molecular orbital program
inferredcites →https://doi.org/10.1007/s003950050157openalex-snapshot
The dual role of the urokinase receptor system in pericellular proteolysis and cell adhesion: implications for cardiovascular function
inferredcites →https://doi.org/10.1016/0024-3205(80)90067-3openalex-snapshot
Activation of human breast carcinoma collagenase through plasminogen activator
inferredcites →https://doi.org/10.1016/0092-8674(86)90613-6openalex-snapshot
Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
inferredcites →https://doi.org/10.1016/0169-5002(94)00408-fopenalex-snapshot
The plasminogen activation system and its role in lung cancer. A review
inferredcites →https://doi.org/10.1016/0268-9499(92)90090-5openalex-snapshot
Competitive inhibitors of human urokinase
inferredcites →https://doi.org/10.1016/j.bmc.2004.02.019openalex-snapshot
3D-QSAR CoMFA/CoMSIA studies on Urokinase plasminogen activator (uPA) inhibitors: a strategic design in novel anticancer agents
inferredcites →https://doi.org/10.1016/j.bmc.2005.02.027openalex-snapshot
3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis
inferredcites →https://doi.org/10.1016/j.bmcl.2004.03.094openalex-snapshot
Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-Isoquinolinylguanidines
inferredcites →https://doi.org/10.1016/j.bmcl.2004.10.026openalex-snapshot
Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties
inferredcites →https://doi.org/10.1016/s0960-894x(01)00247-5openalex-snapshot
Structure-Based design, synthesis and sAR of a novel series of thiopheneamidine urokinase plasminogen activator inhibitors
inferredcites →https://doi.org/10.1016/s0960-894x(01)00787-9openalex-snapshot
Design and Synthesis of 4,5-Disubstituted-thiophene-2-amidines as Potent Urokinase Inhibitors
inferredcites →https://doi.org/10.1016/s0960-894x(02)00311-6openalex-snapshot
2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors
inferredcites →https://doi.org/10.1016/s0960-894x(02)00312-8openalex-snapshot
4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors
inferredcites →https://doi.org/10.1016/s0967-5868(02)00328-4openalex-snapshot
The role of the plasminogen activation cascade in glioma cell invasion: a review
inferredcites →https://doi.org/10.1016/s0968-0896(00)82150-1openalex-snapshot
The synthesis of three 4-substitutedbenzo[b]thiophene-2-carboxamidines as potent and selective inhibitors of urokinase
inferredcites →https://doi.org/10.1016/s0969-2126(00)00136-2openalex-snapshot
Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite
inferredcites →https://doi.org/10.1021/bi010186uopenalex-snapshot
Species Specificity of Amidine-Based Urokinase Inhibitors
inferredcites →https://doi.org/10.1021/jm00050a010openalex-snapshot
Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological Activity
inferredcites →https://doi.org/10.1021/jm00173a008openalex-snapshot
Selective inhibition of urokinase by substituted phenylguanidines: quantitative structure-activity relationship analyses
inferredcites →https://doi.org/10.1021/jm00173a009openalex-snapshot
(R)-4-Oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex
inferredcites →https://doi.org/10.1021/jm00356a036openalex-snapshot
Aromatic amidines. Comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin
inferredcites →https://doi.org/10.1021/jm00356a037openalex-snapshot
Syntheses of iron(II) bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivatives
inferredcites →https://doi.org/10.1021/jm0100638openalex-snapshot
Development of Serine Protease Inhibitors Displaying a Multicentered Short (<2.3 Å) Hydrogen Bond Binding Mode: Inhibitors of Urokinase-Type Plasminogen Activator and Factor Xa
inferredcites →https://doi.org/10.1021/jm010244+openalex-snapshot
Exploiting Subsite S1 of Trypsin-Like Serine Proteases for Selectivity: Potent and Selective Inhibitors of Urokinase-Type Plasminogen Activator
inferredcites →https://doi.org/10.1021/jm0300072openalex-snapshot
Identification of Novel Binding Interactions in the Development of Potent, Selective 2-Naphthamidine Inhibitors of Urokinase. Synthesis, Structural Analysis, and SAR of N -Phenyl Amide 6-Substitution
inferredcites →https://doi.org/10.1038/ng1297-439openalex-snapshot
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
inferredcites →https://doi.org/10.1042/bst0300207openalex-snapshot
Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers
inferredcites →https://doi.org/10.1054/fipr.2000.0079openalex-snapshot
The urokinase plasminogen activator system as a novel target for tumour therapy
inferredcites →https://doi.org/10.1056/nejm197705052961801openalex-snapshot
Endogenous Activation of Latent Collagenase by Rheumatoid Synovial Cells
inferredcites →https://doi.org/10.1073/pnas.97.10.5113openalex-snapshot
(4-Aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase
inferredcites →https://doi.org/10.1074/jbc.275.10.7239openalex-snapshot
Re-engineering of Human Urokinase Provides a System for Structure-based Drug Design at High Resolution and Reveals a Novel Structural Subsite
inferredcites →https://doi.org/10.1111/j.1699-0463.1999.tb01531.xopenalex-snapshot
The urokinase receptor. A cell surface, regulated chemokine
inferredcites →https://doi.org/10.1111/j.1699-0463.1999.tb01534.xopenalex-snapshot
Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types
inferredcites →https://doi.org/10.1137/0905052openalex-snapshot
The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses
inferredcites →https://doi.org/10.1159/000025601openalex-snapshot
Urokinase Plasminogen Activator Colocalizes with CD25+ Cells in Atherosclerotic Vessels
inferredcites →https://doi.org/10.1161/01.atv.15.1.37openalex-snapshot
Augmented Urokinase Receptor Expression in Atheroma
inferredcites →https://doi.org/10.1161/01.atv.17.11.2848openalex-snapshot
Induction of Vascular SMC Proliferation by Urokinase Indicates a Novel Mechanism of Action in Vasoproliferative Disorders
inferredcites →https://doi.org/10.1182/blood.v78.12.3114.3114openalex-snapshot
Basic and clinical aspects of fibrinolysis and thrombolysis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/bkcs.70203openalex-snapshot
Functionalization of fused N ‐heterocyclic frameworks using organometallic reagents: Reactivity, selectivity, and biological application
inferred← citeshttps://doi.org/10.1002/cjoc.201300449openalex-snapshot
Insight into the Structural Requirements of Protoporphyrinogen Oxidase Inhibitors: Molecular Docking and CoMFA of Diphenyl Ether, Isoxazole Phenyl, and Pyrazole Phenyl Ether
inferred← citeshttps://doi.org/10.1002/prot.22579openalex-snapshot
Comparative binding energy analysis for binding affinity and target selectivity prediction
inferred← citeshttps://doi.org/10.1002/qsar.200730053openalex-snapshot
A 3‐D QSAR Study of Catechol‐O‐Methyltransferase Inhibitors Using CoMFA and CoMSIA
inferred← citeshttps://doi.org/10.1007/s00894-018-3582-2openalex-snapshot
Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations
inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.07.051openalex-snapshot
Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents
inferred← citeshttps://doi.org/10.1021/jp5064319openalex-snapshot
Evaluation of Interactions between Urokinase Plasminogen and Inhibitors Using Molecular Dynamic Simulation and Free-Energy Calculation
inferred← citeshttps://doi.org/10.1038/s41598-026-36406-4openalex-snapshot
From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer
inferred← citeshttps://doi.org/10.2174/1871520620666200424132248openalex-snapshot
Isoquinolines: Important Cores in Many Marketed and Clinical Drugs
inferred← citeshttps://doi.org/10.2478/s11696-007-0070-zopenalex-snapshot
Synthesis and antifungal activity of alkyland arylsulfanylpyridinylguanidines
inferred← citeshttps://doi.org/10.5772/27713openalex-snapshot
Inhibitors of Proteinases as Potential Anti-Cancer Agents
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.